Yipinhong announced that its wholly-owned subsidiary Guangzhou Yipinhong Pharmaceutical recently received the “Drug Registration Certificate” for levofloxacin oral solution approved and issued by the State Drug Administration. This drug is a class 3 chemical drug. It is treated as if it has passed the consistency evaluation. It has a wide range of indications and can be used to treat various bacterial infections. In 2024, the sales scale of levofloxacin in domestic cities and county-level public hospitals was about 401 million yuan. This approval makes the company eligible for domestic sales, which will enrich the product pipeline and enhance competitiveness in the anti-infective field, but there is a risk that sales of drugs will fall short of expectations after marketing.

Yipinhong announced that its wholly-owned subsidiary Guangzhou Yipinhong Pharmaceutical recently received the “Drug Registration Certificate” for levofloxacin oral solution approved and issued by the State Drug Administration. This drug is a class 3 chemical drug. It is treated as if it has passed the consistency evaluation. It has a wide range of indications and can be used to treat various bacterial infections. In 2024, the sales scale of levofloxacin in domestic cities and county-level public hospitals was about 401 million yuan. This approval makes the company eligible for domestic sales, which will enrich the product pipeline and enhance competitiveness in the anti-infective field, but there is a risk that sales of drugs will fall short of expectations after marketing.